Autolus Therapeutics plc - stock earnings

AUTL Quarterly earnings

DateEarningsRevenue
2023Q4 -77.2 million USD ? USD
2023Q3 -45.8 million USD 406000 USD
2023Q2 -45.6 million USD ? USD
2023Q1 -39.8 million USD 1.3 million USD
2022Q4 -27.0 million USD 3.8 million USD
2022Q3 -42.8 million USD 2.4 million USD
2022Q2 -42.1 million USD ? USD
2022Q1 -37.1 million USD 166000 USD
2021Q4 -41.7 million USD 823000 USD
2021Q3 -34.0 million USD 236000 USD
2021Q2 -33.2 million USD 1.5 million USD
2021Q1 -33.3 million USD 269000 USD
2020Q4 -42.9 million USD -873000 USD
2020Q3 -37.3 million USD 242000 USD
2020Q2 -32.0 million USD 293000 USD
2020Q1 -29.9 million USD 338000 USD
2019Q4 -40.9 million USD 309000 USD
2019Q3 -27.2 million USD 297000 USD
2019Q2 -28.5 million USD 338000 USD
2019Q1 -27.2 million USD 2.0 million USD
2018Q4 -20.6 million USD 296000 USD
2018Q3 -10.3 million USD 296000 USD
2018Q2 -10.3 million USD 375000 USD
2018Q1 ? USD 657000 USD
2017Q4 -12.1 million USD 328500 USD
2017Q3 -19.7 million USD 812000 USD
2017Q2 3.8 million USD 881000 USD
2017Q1 ? USD 881000 USD
2016Q4 -3.8 million USD 440500 USD
2016Q3 -12.6 million USD 1.2 million USD

AUTL Yearly earnings

DateEarningsRevenue
2023 -208.4 million USD 1.7 million USD
2022 -148.8 million USD 6.2 million USD
2021 -142.1 million USD 2.3 million USD
2020 -142.1 million USD 242000 USD
2019 -123.8 million USD 2.9 million USD
2018 -31.1 million USD 1.0 million USD
2017 -19.7 million USD 1.7 million USD
2016 -12.6 million USD 1.2 million USD
2015 -4.9 million USD 62194 USD

AUTL

Price: $4.08

52 week price:
1.61
7.45

Earnings Per Share: -1.20 USD

P/E Ratio: -6.15

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 412700

Market Capitalization: 1.3 billion

Links: